Eric Dube Named a CEO of the Year by San Diego Business Journal

Wednesday, July 19, 2023 – For his success in Travere Therapeutics’ business growth and commitment to supporting biotech and wellness, San Diego Business Journal named Eric Dube, Ph.D., CEO of the Year in the Medium-Size Company Category.

“I feel like I have the greatest job in the world. I work with individuals who are so incredibly talented and committed to one purpose – and that’s to bring innovation to families that may be suffering and may not otherwise have hope for a treatment for their rare disease. I see the CEO role in biotech as one of finding great people and then giving them the vision and space to do their great work,” Eric said.

Travere Therapeutics Enters Agreement to Sell its Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases to Mirum Pharmaceuticals

Travere Therapeutics to Report Second Quarter 2023 Financial Results